Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
Navigating Technology Transfer
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
View All Featured ArticlesHeadline News
RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer
Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer
FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Latest Analytical Techniques in Extractable and Leachables
Presented by Dr. Tom van Wijk, Abbott Healthcare Products BV, Weesp, Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis
20th May 2021
Just in Time Release of CAR T Cell Therapies During Covid-19
Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
29th November 2021
Data as an asset – what does this mean to you?
Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Klaus Mauch, CEO at Yokogawa Insilico Biotechnology GmbH
12th April 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
